Insights On Pharmaceutical Packaging
-
Successfully Navigating Opportunities With On-Body Delivery Systems
4/23/2026
Drawing on insights from the global regulatory landscape, industry trends, and direct feedback from customers, Dr. Di Wu addresses some of the most frequently asked questions about on-body delivery system requirements.
-
Implementing Medium And High-Volume Drug Handling And Packaging Programs
4/23/2026
Simplify the complexity of combination product development by partnering for integrated support across device design, industrialization, manufacturing, and final product assembly.
-
West Vantage⢠Goes Beyond Contract Manufacturing
4/23/2026
Successfully advancing a drug-delivery device to market demands more than technical expertise; it requires coordinated execution, regulatory insight, and the ability to scale without disruption.
-
6 Strategic Pillars For Selecting A Drug Packaging Partner
4/14/2026
Early engagement with an expert packaging partner supports safe, cost-effective drug development and logistical success from precommercial stages through full market launch.
-
The Future Of Pharma Packaging Trends, Technologies, And Patient-Centric Solutions
4/14/2026
Pharmaceutical packaging must evolve alongside drug development to ensure stability, safety, and regulatory adherence, utilizing innovative designs to improve therapeutic outcomes and patient accessibility.
-
Clinical, Commercial Packaging: Delivering Next-Gen Therapies
4/7/2026
See how strategic, agile, and sustainable packaging is transforming drug delivery into a key driver of speed, safety, and patient-centric innovation.
-
Cutting Through Complexity: An Integrated Model For Faster PFS Development
4/7/2026
Discover how integrated, end-to-end development for prefilled syringes can streamline timelines, enhance patient-centric delivery, and scale efficiently from early development to global launch.
-
The Effect Of Conventional Cooling Versus Controlled Ice Nucleation On Primary Drying Time
4/1/2026
See how controlled ice nucleation shortens lyophilization cycles, supports higher drying temperatures, and reduces complexity for amorphous and mixed formulations without sacrificing quality.
-
Quick View Of Asymchem's New OEB5 Facility
3/12/2026
Explore Asymchem’s OEB5 high-potency facility — a 6,000 m², fully enclosed site integrating R&D, manufacturing, and analytics under CPT ≤1 ng/m³ containment.
-
Asymchem's State-Of-The-Art HTE Platform
3/12/2026
Steve Fussell, Senior Manager – High-Throughput Experimentation (HTE) at Asymchem, introduces our state-of-the-art HTE laboratory, where automation, robotics, and data-driven insights transform process R&D.